Recently Updated Advisory Committee Materials

Recently Updated Advisory Committee Materials

Posted on March 19, 2012

Oncologic Drugs Advisory Committee

• Briefing Information for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee
• Talon Briefing Information, Marqibo (vincristine sulfate liposomes injection), for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 2.46MB)  (PDF - 2.4MB)
• FDA Briefing Information, Marqibo (vincristine sulfate liposomes injection), for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee (PDF – 210KB)  (PDF - 209KB)
• Webcast Information for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 26KB)
• Committee Roster for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 15KB)
• Draft Questions for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 16KB)
• Draft Meeting Roster for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 30KB)
• Draft Agenda for the March 21, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 15KB)
• 2012 Meeting Materials, Oncologic Drugs Advisory Committee

Advisory Committee Calendar

• April 25-26, 2012: Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting Announcement

-

Posted on March 17, 2012

Oncologic Drugs Advisory Committee

• Webcast Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 26KB)
• Committee Roster for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 15KB)
• Draft Meeting Roster for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 31KB)

-

Posted on March 16, 2012

Oncologic Drugs Advisory Committee

• FDA Briefing Information, RIDAFOROLIMUS Tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 227KB)
• Errata to the FDA Briefing Information, VOTRIENT (PAZOPANIB) Tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 27KB)
• FDA Briefing Information, VOTRIENT (PAZOPANIB) Tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 274KB)
• Briefing Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee
• MERCK Briefing Information, RIDAFOROLIMUS Tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 1.1MB)
• GSK Briefing Information, VOTRIENT (PAZOPANIB) Tablets, for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 525KB)
• Draft Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (PM Session)  (PDF - 16KB)
• Draft Questions for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee (AM Session)  (PDF - 16KB)
• Draft Agenda for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 21KB)